The dispute between Boston Scientific Corp. and Johnson & Johnson that started with an intense bidding war in late 2005 has now finally been settled.
Boston Scientific said Feb. 17 that it will pay J&J $600 million to settle allegations that cardiovascular device firm Guidant Corp. breached a merger agreement [See Deal]...